Thursday, May 19, 2022
SCIENMAG: Latest Science and Health News
No Result
View All Result
  • Login
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
No Result
View All Result
Scienmag - Latest science news from science magazine
No Result
View All Result
Home SCIENCE NEWS Social & Behavioral Science

Researchers at the GIST identify new medicines using interpretable deep learning predictions

April 5, 2022
in Social & Behavioral Science
0
Share on FacebookShare on Twitter

An important aspect of drug discovery involves determining how well a drug binds to its target (protein) molecule. Typically, this step involves aligning a 3D structure of a drug and its target protein at various configurations in a process called “docking.” Preferred binding sites are then discovered by running docking simulations repeatedly with multiple drug candidates for a particular target molecule. Typically, owing to the vast number of likely candidates for potential drug-target interactions, deep learning models are used to carry out such simulations. However, a problem with using such models is the difficulty in interpreting their predictions. While deep learning certainly makes for a speedy drug discovery, it is little more than a black box. Additionally, docking simulations cannot be used to develop drugs for novel targets that have no known 3D complex with an interacting drug.

Researchers at the GIST Identify New Medicines Using Interpretable Deep Learning Predictions

Credit: Gwangju Institute of Science and Technology (GIST)

An important aspect of drug discovery involves determining how well a drug binds to its target (protein) molecule. Typically, this step involves aligning a 3D structure of a drug and its target protein at various configurations in a process called “docking.” Preferred binding sites are then discovered by running docking simulations repeatedly with multiple drug candidates for a particular target molecule. Typically, owing to the vast number of likely candidates for potential drug-target interactions, deep learning models are used to carry out such simulations. However, a problem with using such models is the difficulty in interpreting their predictions. While deep learning certainly makes for a speedy drug discovery, it is little more than a black box. Additionally, docking simulations cannot be used to develop drugs for novel targets that have no known 3D complex with an interacting drug.

In a recent study published in the Journal of Cheminformatics, Associate professor Hojung Nam and her Ph.D. student Ingoo Lee from the Gwangju Institute of Science and Technology in Korea developed an new deep learning model called “Highlights on Target Sequences” (HoTS) for predicting the binding between a drug and a target molecule. The new model not only makes better predictions but, more interestingly, did so in an interpretable manner. Moreover, the model could predict drug-target interactions (DTIs) without the need for simulations or 3D structures.

How did the team achieve this remarkable feat? Professor Nam explains how their drug-target interaction prediction model works: “First, we explicitly teach the model which parts of a protein sequence will interact with the drug using prior knowledge. The trained model is then utilized to recognize and predict interactions between drugs and target proteins, giving better prediction performances. Using this, we built a model that can predict the target proteins’ binding regions and their interactions with drugs without a 3D-complex.”

Rather than dealing with the complete length of the protein sequence, the model could make predictions based only on the parts of the protein that are relevant to the DTI interaction. “We taught the model where to ‘focus’ to ensure that it can comprehend important sub-regions of proteins in predicting its interaction with candidate drugs,” elaborates Professor Nam. This, in turn, allowed the model to predict DTIs more accurately than existing models.

Considering that the model does not require information about the 3D structure and provides predictions that are clearly understandable, the findings of this study provide a good starting point for further docking simulations to predict new drug candidates for targeted therapy, accelerating advancements in this field. “The model used in our study would make the drug discovery process more transparent as well as low-risk and low-cost. This will allow researchers to discover more drugs for the same amount of budget and time,” concludes Professor Nam.

Let’s hope her visions are not too far from being realized!

 

***

 

Reference

DOI: https://doi.org/10.1186/s13321-022-00584-w

Authors: Ingoo Lee, Hojung Nam

Affiliations: Gwangju Institute of Science and Technology, Republic of Korea

 

About the Gwangju Institute of Science and Technology (GIST)

The Gwangju Institute of Science and Technology (GIST) was founded in 1993 by the Korean government as a research-oriented graduate school to help ensure Korea’s continued economic growth and prosperity by developing advanced science and technology with an emphasis on collaboration with the international community. Since that time, GIST has pioneered a highly regarded undergraduate science curriculum in 2010 that has become a model for other science universities in Korea. To learn more about GIST and its exciting opportunities for researchers and students alike, please visit: http://www.gist.ac.kr/.

 

About the author

Hojung Nam is an Associate Professor in the School of Electrical Engineering and Computer Science at the Gwangju Institute of Science and Technology (GIST). Her research group is developing various computational tools for drug discovery and development. For example, her group created a computational model to predict side effects caused by drug-drug interactions, predicting drug responses for patients, and developed generative models for novel molecules. Before coming to GIST, she completed her postdoctoral training in the Department of Bioengineering at University of California in San Diego (UCSD). In 2009, Hojung Nam received a Ph.D. in the Department of Bio and Brain Engineering at the Korean Advanced Institute of Science and Technology (KAIST).

Ingoo Lee is a Ph.D. candidate under her advisor Professor Hojung Nam at GIST. During his Ph.D. training, he has shown great progress in building drug-target interactions prediction models.



Journal

Journal of Cheminformatics

DOI

10.1186/s13321-022-00584-w

Method of Research

Computational simulation/modeling

Subject of Research

Not applicable

Article Title

Sequence-based prediction of protein binding regions and drug–target interactions

Article Publication Date

8-Feb-2022

COI Statement

The authors declare no competing interests.

Tags: deepGISTidentifyinterpretablelearningMedicinespredictionsresearchers
Share26Tweet16Share4ShareSendShare
  • Gladstone scientists Tongcui Ma, Irene Chen, and Rahul Suryawanshi.

    “Natural immunity” from omicron is weak and limited, study finds

    68 shares
    Share 27 Tweet 17
  • Researchers discover genetic cause of megaesophagus in dogs

    1022 shares
    Share 409 Tweet 256
  • Scripps Research awarded $67 million by NIH to lead new Pandemic Preparedness Center

    66 shares
    Share 26 Tweet 17
  • Do early therapies help very young children with or at high likelihood for autism?

    66 shares
    Share 26 Tweet 17
  • Ecological functions of streams and rivers severely affected globally

    71 shares
    Share 28 Tweet 18
  • Null results research now published by major behavioral medicine journal

    310 shares
    Share 124 Tweet 78
ADVERTISEMENT

About us

We bring you the latest science news from best research centers and universities around the world. Check our website.

Latest NEWS

Understanding how sunscreens damage coral

SUTD develops design-based activity to enhance students’ understanding in electrochemistry

New Curtin research resurrects ‘lost’ coral species

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 187 other subscribers

© 2022 Scienmag- Science Magazine: Latest Science News.

No Result
View All Result
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US

© 2022 Scienmag- Science Magazine: Latest Science News.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Posting....